VECT — VectivBio Holding AG Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMid Cap
- $1.06bn
- $846.20m
Annual cashflow statement for VectivBio Holding AG, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -23.5 | -59.9 | -87 | -93.7 |
| Depreciation | ||||
| Non-Cash Items | 3.46 | 19.1 | 18 | 27.5 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | 4.97 | 2.39 | -3.39 | 9.77 |
| Change in Accounts Receivable | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -14.9 | -38.2 | -72.1 | -56.3 |
| Capital Expenditures | -0.056 | -0.093 | -0.057 | -0.074 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0.011 | 0.024 | -6.62 | 0 |
| Acquisition of Business | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -0.045 | -0.069 | -6.67 | -0.074 |
| Financing Cash Flow Items | 0.48 | -1.33 | -12.7 | -13.8 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 32.8 | 56.6 | 141 | 175 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 17.7 | 20.4 | 62.5 | 119 |